Biotech Stock Soars 372% Before Sell-Off as Rival Gains 40% Amid February 2026 Market Volatility | MarketWire

A clinical-stage biotech stock skyrocketed 372% before a sharp sell-off, while another rises 40% amid market shifts in February 2026.